Endologix (NSDQ:ELGX) made progress in its 3rd quarter, narrowing losses despite a $5 million lawsuit loss to Cook Medical.
MassDevice Earnings Roundup
EnteroMedics cuts losses in Q3, aims for 2014 commercialization
EnteroMedics (NSDQ:ETRM) narrowed its losses during its 3rd quarter, cutting its research & development expenses nearly in half.
Dentsply’s a mixed bag in Q3
Dentsply International (NSDQ:XRAY) reported a 12.3% increase in sales during the 3 months ended Sept. 30, 2012, but saw a 11.9% decline in net income.
Varian jumps on strong Q4, 2012 numbers
Shares of Varian Medical Systems (NYSE:VAR) jumps nearly 16% this morning after the medical device company posted 4th-quarter profit growth of more than 19% and full-year earnings growth of 7% even, beating Wall Street’s expectations.
Conceptus is back in the black in Q3
Conceptus (NSDQ:CPTS) touted a Q3 return to the black, back from previous losses reporting for the same period last year.
The Mountain View medical device maker posted $2.3 million net income, or 7¢ per share, on sales of $35.5 million. That compared with net loss of $2.9 million, or 9¢ per share, during the same period last year.
Hill-Rom gains on Q4, 2012 results
Hill-Rom Holdings (NYSE:HRC) added 6% to its share price this week after reporting 4th-quarter and fiscal 2012 profits ahead of analysts’ expectations.
Batesville, Ind.-based Hill-Rom posted Q4 profits of $39.2 million, or 63¢ per share, on sales of $330.1 million for the 3 months ended Sept. 30. That represents a sales increase of 4.4%, but a bottom-line decrease of 38.3%.
NeuroMetrix slides on 3Q results
NeuroMetrix (NSDQ:NURO) reported another consecutive quarter at a net loss, spurring a 9.1% drop on Wall Street yesterday, where shares closed at 50¢.
Palomar’s non-royalty revenues jump 300% in Q3
Palomar Medical (NSDQ:PMTI) made big strides in its professional product revenues during the 3 months ended Sept. 30, 2012, but stayed in the red for the quarter.
The Burlington, Mass.-based aesthetic medical device maker reported a net loss of $4.7 million, or 25¢ per share, on sales of $18.5 million for the 3 months ended Sept. 30.
Device tax: Impact won’t be as bad as we thought, Zimmer execs say
Zimmer Holdings (NYSE:ZMH) may not be as hard hit by the medical device tax as the company had previously estimated, executives said during a conference call with investors today.
The orthopedic devices maker’s supply chain is set up in such a way that when the tax is assessed Zimmer can account for it as a "cost of goods," president & CEO David Dvorak said.
McKesson to pay $2B for PSS World Medical | Wall Street Beat
McKesson (NYSE:MCK) agreed to pay $29 per share for PSS World Medical (NSDQ:PSSI) and its medical supplies business in a deal worth $2.1 billion.
Orthofix drops on Q3 profit slide, lowered guidance
Shares of Orthofix (NSDQ:OFIX) stock shed some 4% of their value today after the medical device company said its 3rd-quarter profits fell and lowered its guidance for the rest of the year.
Lewisville, Texas-based Orthofix reported profits of $7.6 million, or 39¢ per share, on sales of $114.8 million during the 3 months ended Sept. 30, for a 38.7% profit slide and a 2.1% decrease in sales.